Q93096 (TP4A1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 110.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Protein tyrosine phosphatase type IVA 1 EC=3.1.3.48 Alternative name(s): PTP(CAAXI) Protein-tyrosine phosphatase 4a1 Protein-tyrosine phosphatase of regenerating liver 1 Short name=PRL-1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 173 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Protein tyrosine phosphatase which stimulates progression from G1 into S phase during mitosis. May play a role in the development and maintenance of differentiating epithelial tissues. Enhances cell proliferation, cell motility and invasive activity, and promotes cancer metastasis. Ref.10 Ref.12 Ref.13 |
| Catalytic activity | Protein tyrosine phosphate + H2O = protein tyrosine + phosphate. Ref.1 |
| Enzyme regulation | Inhibited by sodium orthovanadate and pentamidine. Ref.11 |
| Subunit structure | Homotrimer. Interacts with ATF5 By similarity. Interacts with tubulin. Ref.10 Ref.16 |
| Subcellular location | Cell membrane. Early endosome. Endoplasmic reticulum. Cytoplasm. Cytoplasm › cytoskeleton › spindle. Note: And mitotic spindle. Ref.9 Ref.10 Ref.16 |
| Tissue specificity | Expressed in bone marrow, lymph nodes, T lymphocytes, spleen, thymus and tonsil. Overexpressed in tumor cell lines. Ref.9 Ref.10 |
| Developmental stage | Expressed in fetal liver. Ref.9 |
| Induction | Strongly down-regulated upon tetrodotoxin treatment. Ref.11 Ref.14 |
| Post-translational modification | Farnesylated. Farnesylation is required for membrane targeting. Unfarnesylated forms are shifted into the nucleus. |
| Sequence similarities | Belongs to the protein-tyrosine phosphatase family. Contains 1 tyrosine-protein phosphatase domain. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 170 | 170 | Protein tyrosine phosphatase type IVA 1 | PRO_0000094780 | ||||||||||||||||||||||||||||||||
| Propeptide | 171 – 173 | 3 | Removed in mature form Probable | PRO_0000396726 | ||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||
| Domain | 82 – 148 | 67 | Tyrosine-protein phosphatase | |||||||||||||||||||||||||||||||||
| Region | 97 – 132 | 36 | Interaction with ATF5 By similarity | |||||||||||||||||||||||||||||||||
| Region | 105 – 110 | 6 | Phosphate binding | |||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||
| Active site | 72 | 1 | Proton donor Probable | |||||||||||||||||||||||||||||||||
| Active site | 104 | 1 | Phosphocysteine intermediate | |||||||||||||||||||||||||||||||||
| Binding site | 110 | 1 | Substrate | |||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||
| Modified residue | 170 | 1 | Cysteine methyl ester Probable | |||||||||||||||||||||||||||||||||
| Lipidation | 170 | 1 | S-farnesyl cysteine Ref.1 | |||||||||||||||||||||||||||||||||
| Disulfide bond | 49 ↔ 104 | Ref.16 | ||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||
| Mutagenesis | 13 | 1 | T → F: Reduces trimerization. Ref.16 | |||||||||||||||||||||||||||||||||
| Mutagenesis | 71 | 1 | D → A: No effect on catalytic activity. Ref.10 | |||||||||||||||||||||||||||||||||
| Mutagenesis | 72 | 1 | D → A: 80% loss of catalytic activity; delay in progression through G2/M. Ref.10 | |||||||||||||||||||||||||||||||||
| Mutagenesis | 104 | 1 | C → S: Abolishes enzymatic activity. Ref.10 | |||||||||||||||||||||||||||||||||
| Mutagenesis | 131 | 1 | Q → A: Reduces trimerization. Ref.16 | |||||||||||||||||||||||||||||||||
| Mutagenesis | 170 | 1 | C → S: Redistributes to the nucleus in resting cells, but still locates to the mitotic spindle in dividing cells. Induces defects in cytokinesis. Ref.10 | |||||||||||||||||||||||||||||||||
| Mutagenesis | 171 | 1 | C → S: No effect on subcellular location. Ref.10 | |||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||
| Beta strand | 10 – 14 | 5 | ||||||||||||||||||||||||||||||||||
| Beta strand | 17 – 21 | 5 | ||||||||||||||||||||||||||||||||||
| Helix | 27 – 29 | 3 | ||||||||||||||||||||||||||||||||||
| Helix | 30 – 39 | 10 | ||||||||||||||||||||||||||||||||||
| Beta strand | 42 – 47 | 6 | ||||||||||||||||||||||||||||||||||
| Helix | 56 – 60 | 5 | ||||||||||||||||||||||||||||||||||
| Beta strand | 64 – 67 | 4 | ||||||||||||||||||||||||||||||||||
| Beta strand | 72 – 74 | 3 | ||||||||||||||||||||||||||||||||||
| Helix | 78 – 94 | 17 | ||||||||||||||||||||||||||||||||||
| Beta strand | 99 – 103 | 5 | ||||||||||||||||||||||||||||||||||
| Beta strand | 105 – 108 | 4 | ||||||||||||||||||||||||||||||||||
| Turn | 109 – 111 | 3 | ||||||||||||||||||||||||||||||||||
| Helix | 112 – 121 | 10 | ||||||||||||||||||||||||||||||||||
| Helix | 126 – 134 | 9 | ||||||||||||||||||||||||||||||||||
| Helix | 143 – 151 | 9 | ||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases." Cates C.A., Michael R.L., Stayrook K.R., Harvey K.A., Burke Y.D., Randall S.K., Crowell P.L., Crowell D.N. Cancer Lett. 110:49-55(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], ENZYME ACTIVITY, ISOPRENYLATION AT CYS-170. Tissue: Mammary carcinoma. |
| [2] | "The gene encoding human nuclear protein tyrosine phosphatase, PRL-1. Cloning, chromosomal localization, and identification of an intron enhancer." Peng Y., Genin A., Spinner N.B., Diamond R.H., Taub R. J. Biol. Chem. 273:17286-17295(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. Tissue: Regenerating liver. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Thalamus. |
| [4] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Fetal liver. |
| [5] | "The DNA sequence and analysis of human chromosome 6." Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. Beck S.Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Muscle and Testis. |
| [8] | "Multiple phosphotyrosine phosphatase mRNAs are expressed in the human lung fibroblast cell line WI-38." Dayton M.A., Knobloch T.J. Recept. Signal Transduct. 7:241-256(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 80-163. Tissue: Lung fibroblast. |
| [9] | "Subcellular localization of intracellular protein tyrosine phosphatases in T cells." Gjoerloff-Wingren A., Saxena M., Han S., Wang X., Alonso A., Renedo M., Oh P., Williams S., Schnitzer J., Mustelin T. Eur. J. Immunol. 30:2412-2421(2000) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE. |
| [10] | "The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum and the mitotic spindle and is required for normal mitosis." Wang J., Kirby C.E., Herbst R. J. Biol. Chem. 277:46659-46668(2002) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, TISSUE SPECIFICITY, MUTAGENESIS OF ASP-71; ASP-72; CYS-104; CYS-170 AND CYS-171, INTERACTION WITH TUBULIN, FUNCTION. |
| [11] | "Pentamidine is an inhibitor of PRL phosphatases with anticancer activity." Pathak M.K., Dhawan D., Lindner D.J., Borden E.C., Farver C., Yi T. Mol. Cancer Ther. 1:1255-1264(2002) [PubMed] [Europe PMC] [Abstract] Cited for: ENZYME REGULATION. |
| [12] | "Enhanced cell cycle progression and down regulation of p21(Cip1/Waf1) by PRL tyrosine phosphatases." Werner S.R., Lee P.A., DeCamp M.W., Crowell D.N., Randall S.K., Crowell P.L. Cancer Lett. 202:201-211(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [13] | "PRL-3 and PRL-1 promote cell migration, invasion, and metastasis." Zeng Q., Dong J.-M., Guo K., Li J., Tan H.-X., Koh V., Pallen C.J., Manser E., Hong W. Cancer Res. 63:2716-2722(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [14] | "Potential effects of tetrodotoxin exposure to human glial cells postulated using microarray approach." Raghavendra Prasad H.S., Qi Z., Srinivasan K.N., Gopalakrishnakone P. Toxicon 44:597-608(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INDUCTION. |
| [15] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [16] | "Trimeric structure of PRL-1 phosphatase reveals an active enzyme conformation and regulation mechanisms." Jeong D.G., Kim S.J., Kim J.H., Son J.H., Park M.R., Lim S.M., Yoon T.-S., Ryu S.E. J. Mol. Biol. 345:401-413(2005) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF MUTANT SER-104, DISULFIDE BOND, SUBCELLULAR LOCATION, SUBUNIT, MUTAGENESIS OF THR-13 AND GLN-131, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U48296 mRNA. Translation: AAB40597.1. AF051160 Genomic DNA. Translation: AAC39836.1. AK312526 mRNA. Translation: BAG35425.1. CR749458 mRNA. Translation: CAH18292.1. AL135905 Genomic DNA. Translation: CAC12761.1. CH471143 Genomic DNA. Translation: EAW88494.1. BC023975 mRNA. Translation: AAH23975.1. BC045571 mRNA. Translation: AAH45571.1. U69701 mRNA. Translation: AAB09080.1. | ||||||||||||||||||
| IPI | IPI00020164. | ||||||||||||||||||
| RefSeq | NP_003454.1. NM_003463.3. | ||||||||||||||||||
| UniGene | Hs.227777. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| DisProt | DP00255. | ||||||||||||||||||
| ProteinModelPortal | Q93096. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | Q93096. 3 interactions. | ||||||||||||||||||
| STRING | 9606.ENSP00000359685. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | Q93096. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 68566217. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PaxDb | Q93096. | ||||||||||||||||||
| PRIDE | Q93096. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| DNASU | 7803. | ||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000370651; ENSP00000359685; ENSG00000112245. | ||||||||||||||||||
| GeneID | 7803. | ||||||||||||||||||
| KEGG | hsa:7803. | ||||||||||||||||||
| UCSC | uc003pek.3. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 7803. | ||||||||||||||||||
| GeneCards | GC06P064279. | ||||||||||||||||||
| HGNC | HGNC:9634. PTP4A1. | ||||||||||||||||||
| HPA | HPA003281. | ||||||||||||||||||
| MIM | 601585. gene. | ||||||||||||||||||
| neXtProt | NX_Q93096. | ||||||||||||||||||
| PharmGKB | PA33977. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | NOG265664. | ||||||||||||||||||
| HOGENOM | HOG000231265. | ||||||||||||||||||
| HOVERGEN | HBG071295. | ||||||||||||||||||
| InParanoid | Q93096. | ||||||||||||||||||
| KO | K01104. | ||||||||||||||||||
| OMA | CEATYDA. | ||||||||||||||||||
| OrthoDB | EOG4ZCT5N. | ||||||||||||||||||
| PhylomeDB | Q93096. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Pathway_Interaction_DB | prlsignalingeventspathway. Signaling events mediated by PRL. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | Q93096. | ||||||||||||||||||
| Bgee | Q93096. | ||||||||||||||||||
| CleanEx | HS_PTP4A1. | ||||||||||||||||||
| Genevestigator | Q93096. | ||||||||||||||||||
| GermOnline | ENSG00000112245. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR000387. Tyr/Dual-sp_Pase. IPR000242. Tyr_Pase_rcpt/non-rcpt. [Graphical view] | ||||||||||||||||||
| Pfam | PF00102. Y_phosphatase. 1 hit. [Graphical view] | ||||||||||||||||||
| PROSITE | PS00383. TYR_PHOSPHATASE_1. False negative. PS50056. TYR_PHOSPHATASE_2. 1 hit. PS50055. TYR_PHOSPHATASE_PTP. False negative. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| BindingDB | Q93096. | ||||||||||||||||||
| ChEMBL | CHEMBL1075169. | ||||||||||||||||||
| EvolutionaryTrace | Q93096. | ||||||||||||||||||
| GenomeRNAi | 7803. | ||||||||||||||||||
| NextBio | 30184. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | TP4A1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q93096 Secondary accession number(s): B2R6C8, O00648, Q49A54 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 6 Human chromosome 6: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
